The potential for vaccine development against chlamydial infection and disease.
about
Eradicating infectious disease: can we and should we?Surface expression, single-channel analysis and membrane topology of recombinant Chlamydia trachomatis Major Outer Membrane ProteinA live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.Seroprevalence of antibodies against Pkn1, a novel potential immunogen, in Chlamydia trachomatis-infected Macaca nemestrina and human patients.Immunity to murine chlamydial genital infection.CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.Chlamydia trachomatis vaccine research through the years.A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates.Delivery of Chlamydia vaccines.Prediction of the membrane-spanning beta-strands of the major outer membrane protein of Chlamydia.Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.Animal models for studying female genital tract infection with Chlamydia trachomatisBiophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane proteinEvolutionary dynamics of ompA, the gene encoding the Chlamydia trachomatis key antigen.Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination.Local markers for prediction of women at higher risk of developing sequelae to Chlamydia trachomatis infection.
P2860
Q21131227-88372BB0-09EA-40E1-9EDD-808FDAD8AE9DQ24793733-6EB487BE-1ABA-449E-BB28-148D9C29FD44Q33716068-A1D959A2-57AA-4BEF-8D85-88D8CC33891AQ33861740-95B84A2F-8653-4520-8B7F-5D83B473A10EQ34124225-D3C3E67F-A4A9-4BE0-9F3C-1B30CC2FF4A4Q34177368-88ABA193-7A5B-425B-8CE6-4FE6CE15AB2AQ34739969-6F78DA3D-E951-431F-BE41-9255039992FBQ34773772-97AF73A8-5153-4889-AD82-5F478D7C40F0Q35071155-62FD041B-32FC-46E4-9F26-E06BC6C09CE9Q35441545-CF970380-0F30-455F-9FD9-8C1C03FAD538Q36316798-4BBA7042-556C-42BB-9591-C5C16A88F961Q36639464-6660BCF3-6770-4475-8E7D-A274EF93D62BQ36827004-A41E5923-15FC-4BB5-AC0B-39E77FC80515Q37123840-41F1AD82-5F6F-4A4C-969A-A11EDEB5B422Q37376415-05689BDE-692C-46B9-8A83-DA751AC7595BQ37451411-E5AB4C7B-BF4B-49E7-87C7-69EA081D99D2Q37859692-772E463A-8383-4375-B95F-034B1BB2B806Q37860571-6B0F3FD5-93E4-4E37-8393-60BF146A0578
P2860
The potential for vaccine development against chlamydial infection and disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The potential for vaccine development against chlamydial infection and disease.
@ast
The potential for vaccine development against chlamydial infection and disease.
@en
type
label
The potential for vaccine development against chlamydial infection and disease.
@ast
The potential for vaccine development against chlamydial infection and disease.
@en
prefLabel
The potential for vaccine development against chlamydial infection and disease.
@ast
The potential for vaccine development against chlamydial infection and disease.
@en
P2093
P2860
P356
P1476
The potential for vaccine development against chlamydial infection and disease.
@en
P2093
P2860
P304
P356
10.1086/315630
P407
P478
181 Suppl 3
P577
2000-06-01T00:00:00Z